Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
-100.63%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 734 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
enVVeno Medical Corporation
Market Cap
$5.60M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.63M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.77M
Operating Margin
-9154.62%
TTM Avg
-6279.74%
3Y Avg
-3924.25%
5Y Avg
-3328.36%
Market Cap
$5.85M
Operating Margin
-319.16%
TTM Avg
-401.68%
3Y Avg
-560.86%
5Y Avg
-642.19%
Market Cap
$5.21M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.24M
Operating Margin
-305.03%
TTM Avg
-323.91%
3Y Avg
-495.10%
5Y Avg
-376.97%
Market Cap
$5.24M
Operating Margin
0.00%
TTM Avg
-62.53%
3Y Avg
-159.78%
5Y Avg
-184.56%
Market Cap
$5.24M
Operating Margin
-3317.65%
TTM Avg
-1658.83%
3Y Avg
-2341.84%
5Y Avg
-1561.23%
Market Cap
$5.91M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-71.62%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| enVVeno Medical Corporation (NVNO) | $5.60M | 0.00% | 0.00% | 0.00% | 0.00% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.77M | -9154.62% | -6279.74% | -3924.25% | -3328.36% |
| Lucyd, Inc (LUCY)vs › | $5.85M | -319.16% | -401.68% | -560.86% | -642.19% |
| Alzamend Neuro Inc (ALZN)vs › | $5.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.24M | -305.03% | -323.91% | -495.10% | -376.97% |
| Pulmatrix, Inc. (PULM)vs › | $5.24M | 0.00% | -62.53% | -159.78% | -184.56% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.24M | -3317.65% | -1658.83% | -2341.84% | -1561.23% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.91M | 0.00% | 0.00% | 0.00% | -71.62% |
| Lunai Bioworks Inc. (LNAI)vs › | $5.21M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | -5064.63% |
| 2018-12-31 | -5905.47% |
| 2018-09-30 | -3570.75% |
| 2018-06-30 | -3732.81% |
| 2018-03-31 | -4688.35% |
| 2017-12-31 | -1101.34% |
| 2017-09-30 | -6499.91% |
| 2017-06-30 | -3174.60% |
| 2017-03-31 | -627.05% |
| 2016-12-31 | -532.53% |
| 2016-09-30 | -358.85% |
| 2016-06-30 | -801.55% |
| 2016-03-31 | -801.54% |
| 2015-12-31 | 0.00% |
